Relugolix trials for Prostate Adenocarcinoma

All Relugolix trials · All Prostate Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Relugolix for Prostate Adenocarcinoma

• Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
  NCT07025369 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
  NCT06330805 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
  NCT06499870 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
  NCT04423211 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 341 locations

Common questions

How many trials study Relugolix for Prostate Adenocarcinoma?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.